Publication
Title
Cefepime and mortality: A real issue?
Author
Abstract
The fourth-generation cephalosporin, cefepime, has an antimicrobial spectrum that makes it a valuable antibiotic for empirical treatment of neutropenic fever. Randomized trials have proven the efficacy and safety of cefepime in neutropenic fever. However, 2 recent meta-analyses have shown an increased all-cause mortality for cefepime. Since then, many clinicians have been left in doubt about the use of cefepime for this indication. In this paper, we put in perspective some of the methodological and clinical issues and call for further clinical analyses.
Language
English
Source (journal)
Scandinavian journal of infectious diseases. - Stockholm
Publication
Stockholm : 2010
ISSN
0036-5548
Volume/pages
42:6-7(2010), p. 545-548
ISI
000279896500024
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 01.03.2012
Last edited 17.10.2017
To cite this reference